Publications by authors named "K Forinash"

Claim this Profile
W
Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours.
X Zhang, M A Blaskovich, K D Forinash, S M Sebti

Br J Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
Ronil A Patel, Kara D Forinash, Roberta Pireddu, Ying Sun, Nan Sun

Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation.
S S Sharma, L Ma, T K Bagui, K D Forinash, W J Pledger

Oncogene· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2).
Roberta Pireddu, Kara D Forinash, Nan N Sun, Mathew P Martin, Shen-Shu Sung

Medchemcomm· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.
Maria E Balasis, Kara D Forinash, Y Ann Chen, William J Fulp, Domenico Coppola

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis